Outcome of 1000 liver cancer patients evaluated at the UPMC liver cancer center

Journal of Gastrointestinal Surgery

Volumn 10, Issue 1, 2006, Pages 63-68

  Geller, David A ^a   Tsung, Allan ^a   Marsh, J Wallis ^a   Dvorchik, Igor ^a   Gamblin, T Clark ^a   Carr, Brian I ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

90yttrium Theraspheres; Hepatocellular carcinoma; Liver; Liver cancer; Radiofrequency ablation; Trans arterial chemoembolization

Indexed keywords

ANTINEOPLASTIC AGENT;

AGE; CATHETER ABLATION; CHEMOEMBOLIZATION; CONFERENCE PAPER; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER RESECTION; LIVER TRANSPLANTATION; LIVER TUMOR; MALE; METASTASIS; MIDDLE AGED; PALLIATIVE THERAPY; PATIENT REFERRAL; SEX DIFFERENCE; STATISTICS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

AGE FACTORS; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER CIRRHOSIS; LIVER FAILURE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PALLIATIVE CARE; PENNSYLVANIA; REFERRAL AND CONSULTATION; SEX FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 29244464375     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gassur.2005.06.032     Document Type: Conference Paper

References (22)

1. F.X. Bosch, J. Ribes, and J. Borras Epidemiology of primary liver cancer Semin Liver Dis 19 1999 271 285
2. J. Ahn, and S.L. Flamm Hepatocellular carcinoma Dis Mon 50 2004 556 573
3. A. Jemal, T. Murray, E. Ward, A. Samuels, R.C. Tiwari, A. Ghafoor, E.J. Feuer, and M.J. Thun Cancer statistics CA Cancer J Clin 55 2005 10 30
4. Poon MA, O'Connell MJ, Moertel CG, Wieand HS, Cullinan SA, Everson LK, Krook JE, Mailliard JA, Laurie JA, Tschetter LK. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. 1989;7:1407-1418.
5. T.J. Song, E.W. Ip, and Y. Fong Hepatocellular carcinoma: current surgical management Gastroenterology 127 2004 S248 S260
6. K.K. Tanabe, S.A. Curley, G.D. Dodd, A.E. Siperstein, and S.N. Goldberg Radiofrequency ablation: the experts weigh in Cancer 100 2004 641 650
7. D.T. Ruan, and R.S. Warren Liver-directed therapies in colorectal cancer Semin Oncol 32 2005 85 94
8. M. Goodman, and D.A. Geller Radiofrequency ablation of hepatocellular carcinoma B. Carr Hepatocellular Cancer 2005 Human Press Totowa 171 183
9. E.K. Abdalla, J.N. Vauthey, L.M. Ellis, V. Ellis, R. Pollock, K.R. Broglio, K. Hess, and S.A. Curley Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases Ann Surg 239 2004 818 825
10. B.I. Carr Hepatocellular carcinoma: current management and future trends Gastroenterology 127 2004 S218 S224
11. O.M. Ebied, M.P. Federle, B.I. Carr, K.M. Pealer, W. Li, N. Amesur, and A. Zajko Evaluation of responses to chemoemoblization in patients with unresectable hepatocellular carcinoma Cancer 97 2003 1042 1050
12. J. Bruix, M. Sala, and J.M. Llovet Chemoembolization for hepatocellular carcinoma Gastroenterology 127 2004 S179 S188
13. B.I. Carr Hepatic arterychemoembolization for advanced stage HCC: experience of 650 patients Hepatogastroenterology 49 2002 79 86
14. 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients Liver Transpl 10 2004 S107 S110
15. C.M. Lo, H. Ngan, W.K. Tso, C.L. Liu, C.M. Lam, R.T. Poon, S.T. Fan, and J. Wong Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 2002 1164 1171
16. J.M. Llovet, M.I. Real, X. Montana, R. Planas, S. Coll, J. Aponte, C. Ayuso, M. Sala, J. Muchart, R. Sola, J. Rodes, and J. Bruix Barcelona Liver Cancer Group. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 2002 1734 1739
17. J.W. Marsh, D.A. Geller, S.D. Finkelstein, J.B. Donaldson, and I. Dvorchik The role of liver transplantation for hepatobiliary malignancy Lancet Oncol 5 2004 480 508
18. J.W. Marsh, S.D. Finkelstein, M.E. Schwartz, M.I. Fiel, and I. Dvorchik Advancing the diagnosis and treatment of hepatocellular carcinoma Liver Transpl 11 2005 469 472
19. S. Roayaie, J.D. Schwartz, M.W. Sung, S.H. Emre, C.M. Miller, G.E. Gondolesi, N.R. Krieger, and M.E. Schwartz Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis Liver Transpl 10 2004 534 540
20. H.B. El-Serag, and A.C. Mason Rising incidence of hepatocellular carcinoma in the United States NEJM 340 1999 745 750
21. L. Rutstein, and D.A. Geller Hepatocellular carcinoma R. Mclntyre Surgical Decision Making 5th ed 2004 Elsevier Science Philadelphia 174 179
22. B.I. Carr, J.W. Marsh, and D.A. Geller Putting it all together: practical guidelines and considerations for physicians B. Carr Hepatocellular Cancer 2005 Human Press Totawa 285 291